Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Clinical trial NCT05138133 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05138133
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2027-02-23
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.